Amy Lungren
Obstetrics & Gynecology · Flower Mound, TXNPI 1891711198
Payments from drug & device makers
Across 377 payments — averaging $14.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Currax Pharmaceuticals LLC$833
- Mayne Pharma Commercial LLC$426
- Astellas Pharma US Inc$418
- Millicent US Inc$277
- Endo Pharmaceuticals Inc.$244
- plus $2K from 33 others
What the payments were for
- Food & beverage$5,46597%
- Education$1673%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 100 | $1,164 |
| Currax Pharmaceuticals LLC | 76 | $833 |
| Mayne Pharma Commercial LLC | 20 | $426 |
| Astellas Pharma US Inc | 16 | $418 |
| Millicent US Inc | 13 | $277 |
| Endo Pharmaceuticals Inc. | 17 | $244 |
| Roche Diagnostics Corporation | 22 | $230 |
| Shield Therapeutics Inc | 6 | $225 |
| Pfizer | 11 | $215 |
| Organon | 12 | $211 |
| Idorsia Pharmaceuticals US Inc | 5 | $85 |
| Agile Therapeutics, Inc. | 5 | $82 |
| Avion Pharmaceuticals | 5 | $82 |
| Vivus LLC | 7 | $80 |
| Bayer | 4 | $79 |
| Novo Nordisk | 5 | $78 |
| Therapeuticsmd, Inc. | 5 | $77 |
| Exeltis, USA Inc. | 4 | $72 |
| Exact Sciences | 4 | $64 |
| Sumitomo Pharma America, Inc. | 3 | $62 |
| Virtus Pharmaceuticals LLC | 3 | $60 |
| Evofem Biosciences, Inc. | 4 | $60 |
| Biogen | 3 | $57 |
| Coopersurgical, Inc. | 3 | $55 |
| Merck | 3 | $43 |
| Lupin Inc. | 3 | $40 |
| Myriad Women's Health, Inc. | 1 | $36 |
| Avanos Medical | 1 | $33 |
| Mylan Pharmaceuticals Inc. | 2 | $32 |
| Cook Medical LLC | 2 | $30 |
| Eisai Inc. | 2 | $29 |
| AMAG Pharmaceuticals, Inc. | 2 | $27 |
| Molnlycke Health Care US, LLC | 1 | $22 |
| Mycovia Pharmaceuticals, Inc. | 1 | $20 |
| Ascend Therapeutics US, LLC | 1 | $20 |
| Duchesnay USA Incorporated | 1 | $17 |
| Boston Scientific | 1 | $17 |
| Mission Pharmacal Company | 2 | $16 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Veozah$125
How this compares
$5,632 in reported general payments places this provider in the 85th percentile of 3,099 obstetrics & gynecology providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 18 | $1,035 |
| ProgesteroneProgesterone, Micronized | 24 | $819 |
| Spironolactone | 20 | $216 |
| Levothyroxine Sodium | 12 | $129 |
| Medroxyprogesterone Acetate | 14 | $71 |
| Zolpidem Tartrate | 11 | $19 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Flower Mound
- Caren ReavesFlower Mound$231K
- Amir JazaeriHouston$19.5M
- Shannon WestinHouston$17.3M
- Monica LopezFort Worth$8.1M
- Cynthia RobbinsFort Worth$7.8M
- John Paul RobertsPlano$4.9M
- Stephen StamatisWeatherford$4.5M
- Parke HedgesSan Antonio$4.2M
- Mary MartinBeaumont$2.8M
- Mark JacobsHouston$2.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.